These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 34995728)
21. Primary hyperoxaluria in a compound heterozygote infant. Mayordomo-Colunga J; Riverol D; Salido E; Santos F World J Pediatr; 2011 May; 7(2):173-5. PubMed ID: 20549407 [TBL] [Abstract][Full Text] [Related]
22. Characteristics of the genotype and phenotype in Chinese primary hyperoxaluria type 1 populations. Zhao F; Li J; Tang L; Li C; Wang W; Ning C Urolithiasis; 2021 Feb; 49(1):17-25. PubMed ID: 32556641 [TBL] [Abstract][Full Text] [Related]
24. Primary hyperoxaluria: Comprehensive mutation screening of the disease causing genes and spectrum of disease-associated pathogenic variants. Abid A; Raza A; Khan AR; Firasat S; Shahid S; Hashmi S; Zafar MN; Sultan S; Khaliq S; Rizvi SA Clin Genet; 2023 Jan; 103(1):53-66. PubMed ID: 36185032 [TBL] [Abstract][Full Text] [Related]
25. [Clinical analysis of seven cases with primary hyperoxaluria type 1 in children]. Liao X; Li YJ; Zhong F; Chen Y; Tan M; Liao YR; Gao Y Zhonghua Er Ke Za Zhi; 2020 Feb; 58(2):129-134. PubMed ID: 32102150 [No Abstract] [Full Text] [Related]
26. Data from a large European study indicate that the outcome of primary hyperoxaluria type 1 correlates with the AGXT mutation type. Mandrile G; van Woerden CS; Berchialla P; Beck BB; Acquaviva Bourdain C; Hulton SA; Rumsby G; Kidney Int; 2014 Dec; 86(6):1197-204. PubMed ID: 24988064 [TBL] [Abstract][Full Text] [Related]
27. Novel findings in patients with primary hyperoxaluria type III and implications for advanced molecular testing strategies. Beck BB; Baasner A; Buescher A; Habbig S; Reintjes N; Kemper MJ; Sikora P; Mache C; Pohl M; Stahl M; Toenshoff B; Pape L; Fehrenbach H; Jacob DE; Grohe B; Wolf MT; Nürnberg G; Yigit G; Salido EC; Hoppe B Eur J Hum Genet; 2013 Feb; 21(2):162-72. PubMed ID: 22781098 [TBL] [Abstract][Full Text] [Related]
28. Possible ethnic associations in primary hyperoxaluria type-III-associated HOGA1 sequence variants. Abid A Mol Biol Rep; 2021 Apr; 48(4):3841-3844. PubMed ID: 33948853 [TBL] [Abstract][Full Text] [Related]
29. Molecular analysis of the AGXT gene in patients suspected with hyperoxaluria type 1 and three novel mutations from Turkey. Isiyel E; Ezgu SA; Caliskan S; Akman S; Akil I; Tabel Y; Akinci N; Ozdogan EB; Ozel A; Eroglu FK; Ezgu FS Mol Genet Metab; 2016 Dec; 119(4):311-316. PubMed ID: 27915025 [TBL] [Abstract][Full Text] [Related]
30. A de novo mutation in the AGXT gene causing primary hyperoxaluria type 1. Williams EL; Kemper MJ; Rumsby G Am J Kidney Dis; 2006 Sep; 48(3):481-3. PubMed ID: 16931222 [TBL] [Abstract][Full Text] [Related]
31. Mutation Hot Spot Region in the HOGA1 Gene Associated with Primary Hyperoxaluria Type 3 in the Chinese Population. Wang W; Liu Y; Kang L; He R; Song J; Li Y; Li J; Yang Y Kidney Blood Press Res; 2019; 44(4):743-753. PubMed ID: 31401635 [TBL] [Abstract][Full Text] [Related]
33. Mutational Analysis of Agxt in Tunisian Population with Primary Hyperoxaluria Type 1. M'dimegh S; Omezzine A; M'barek I; Moussa A; Mabrouk S; Kaarout H; Souche G; Chemli J; Aloui S; Aquaviva-Bourdain C; Achour A; Abroug S; Bouslama A Ann Hum Genet; 2017 Jan; 81(1):1-10. PubMed ID: 27935012 [TBL] [Abstract][Full Text] [Related]
34. Primary hyperoxaluria Type 1: A case report in an extended family with a novel AGXT gene mutation. Abukhatwah MW; Almalki SH; Althobaiti MS; Alharbi AO; Almalki NK; Kamal NM Medicine (Baltimore); 2020 Jun; 99(25):e20371. PubMed ID: 32569165 [TBL] [Abstract][Full Text] [Related]
35. Folding Defects Leading to Primary Hyperoxaluria. Oppici E; Dindo M; Conter C; Borri Voltattorni C; Cellini B Handb Exp Pharmacol; 2018; 245():313-343. PubMed ID: 29071511 [TBL] [Abstract][Full Text] [Related]
36. Comprehensive mutation screening in 55 probands with type 1 primary hyperoxaluria shows feasibility of a gene-based diagnosis. Monico CG; Rossetti S; Schwanz HA; Olson JB; Lundquist PA; Dawson DB; Harris PC; Milliner DS J Am Soc Nephrol; 2007 Jun; 18(6):1905-14. PubMed ID: 17460142 [TBL] [Abstract][Full Text] [Related]
37. Unusual clinical outcome of primary Hyperoxaluria type 1 in Tunisian patients carrying 33_34InsC mutation. Mbarek IB; Mdimeg S; Moussa A; Zellama D; Kaarout H; Abdelmoula J; Achour A; Abroug S; Omezzine A; Bouslama A BMC Nephrol; 2017 Jun; 18(1):195. PubMed ID: 28619084 [TBL] [Abstract][Full Text] [Related]
38. Genotype-phenotype correlation in primary hyperoxaluria type 1: the p.Gly170Arg AGXT mutation is associated with a better outcome. Harambat J; Fargue S; Acquaviva C; Gagnadoux MF; Janssen F; Liutkus A; Mourani C; Macher MA; Abramowicz D; Legendre C; Durrbach A; Tsimaratos M; Nivet H; Girardin E; Schott AM; Rolland MO; Cochat P Kidney Int; 2010 Mar; 77(5):443-9. PubMed ID: 20016466 [TBL] [Abstract][Full Text] [Related]
39. Detection of AGXT bgene mutations by denaturing high-performance liquid chromatography for diagnosis of hyperoxaluria type 1. Pirulli D; Giordano M; Lessi M; Spanò A; Puzzer D; Zezlina S; Boniotto M; Crovella S; Florian F; Marangella M; Momigliano-Richiardi P; Savoldi S; Amoroso A Clin Exp Med; 2001 Jun; 1(2):99-104. PubMed ID: 11699734 [TBL] [Abstract][Full Text] [Related]
40. Mutation spectrum of primary hyperoxaluria type 1 in Tunisia: implication for diagnosis in North Africa. Nagara M; Tiar A; Ben Halim N; Ben Rhouma F; Messaoud O; Bouyacoub Y; Kefi R; Hassayoun S; Zouari N; Ben Ammar MS; Abdelhak S; Chemli J Gene; 2013 Sep; 527(1):316-20. PubMed ID: 23810941 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]